{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T12:23:03Z","timestamp":1754396583819,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Surg Int"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00383-021-05014-w","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T16:44:09Z","timestamp":1632242649000},"page":"249-255","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Surgical considerations for neuroblastoma-associated opsoclonus\u2013myoclonus\u2013ataxia syndrome: a series of 14 patients from a single institution"],"prefix":"10.1007","volume":"38","author":[{"given":"William R.","family":"Johnston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7897-8880","authenticated-orcid":false,"given":"Peter","family":"Mattei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,21]]},"reference":[{"key":"5014_CR1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/978-3-319-27443-0_96","volume-title":"Fundamentals of pediatric surgery","author":"JR Jackson","year":"2017","unstructured":"Jackson JR, Kim ES (2017) Neuroblastoma. In: Mattei P et al (eds) Fundamentals of pediatric surgery. Springer International Publishing, New York, pp 767\u2013775"},{"issue":"6","key":"5014_CR2","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/mpo.1139","volume":"36","author":"R Cooper","year":"2001","unstructured":"Cooper R et al (2001) Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children\u2019s Cancer Group. Med Pediatr Oncol 36(6):623\u2013629","journal-title":"Med Pediatr Oncol"},{"issue":"1","key":"5014_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1542\/peds.109.1.86","volume":"109","author":"WG Mitchell","year":"2002","unstructured":"Mitchell WG et al (2002) Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequalae. Pediatrics 109(1):86\u201398","journal-title":"Pediatrics"},{"key":"5014_CR4","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00415-018-9138-7","volume":"266","author":"SY Oh","year":"2019","unstructured":"Oh SY, Kim JS, Dieterich M (2019) Update on opsoclonus-myoclonus syndrome in adults. J Neurol 266:1541\u20131548","journal-title":"J Neurol"},{"key":"5014_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejpn.2008.04.012","volume":"13","author":"L Raffaghello","year":"2009","unstructured":"Raffaghello L, Conte M, Grandis ED, Pistoia V (2009) Immunological mechanisms in opsoclonus-myoclonus associated neuroblastoma. Eur J Pediatr Neurol 13:219\u2013223","journal-title":"Eur J Pediatr Neurol"},{"issue":"2","key":"5014_CR6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/ana.20539","volume":"58","author":"F Blaes","year":"2005","unstructured":"Blaes F, Preissner KT et al (2005) Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome. Ann Neurol 58(2):313\u2013317","journal-title":"Ann Neurol"},{"issue":"9","key":"5014_CR7","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1212\/WNL.62.9.1526","volume":"62","author":"MR Pranzatelli","year":"2004","unstructured":"Pranzatelli MR, Verhulst SJ et al (2004) B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes. Neurology 62(9):1526\u20131532","journal-title":"Neurology"},{"issue":"15","key":"5014_CR8","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1200\/JCO.2011.37.9990","volume":"30","author":"DR Strother","year":"2012","unstructured":"Strother DR et al (2012) Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of children\u2019s oncology group study P9641. J Clin Oncol 30(15):1842\u20131848","journal-title":"J Clin Oncol"},{"key":"5014_CR9","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00428-002-0747-1","volume":"442","author":"C Gambini","year":"2003","unstructured":"Gambini C et al (2003) Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistological and molecular features of 15 Italian cases. Virchows Arch 442:555\u2013562","journal-title":"Virchows Arch"},{"key":"5014_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.pediatrneurol.2017.04.027","volume":"73","author":"MR Pranzatelli","year":"2017","unstructured":"Pranzatelli MR, Tate ED (2017) Dexamethasone, intravenous immunoglobulin, and rituximab combination immunotherapy for pediatric opsoclonus-myoclonus syndrome. Pediatr Neurol 73:48\u201356","journal-title":"Pediatr Neurol"},{"issue":"1","key":"5014_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S2352-4642(17)30130-X","volume":"2","author":"PA de Alarcon","year":"2018","unstructured":"de Alarcon PA et al (2018) Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial. Lancet Child Adolesc Health 2(1):25\u201334","journal-title":"Lancet Child Adolesc Health"},{"issue":"7","key":"5014_CR12","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1177\/0883073811428816","volume":"27","author":"ED Tate","year":"2012","unstructured":"Tate ED, Pranzatelli MR, Verhulst SJ et al (2012) Active comparator controlled, rater-blinded study of corticotropin-based immunotherapies for opsoclonus-myoclonus syndrome. J Child Neurol 27(7):875\u2013884","journal-title":"J Child Neurol"},{"issue":"02","key":"5014_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1055\/s-0037-1609038","volume":"49","author":"M Pranzatelli","year":"2018","unstructured":"Pranzatelli M, Tate E, Alber M et al (2018) Rituximab, IVIg, and tetracosactide (ACTH1-24) combination immunotherapy (\u201cRITE-CI\u201d) for pediatric opsoclonus-myoclonus syndrome: immunomarkers and clinical observations. Neuropediatrics 49(02):123\u2013134","journal-title":"Neuropediatrics"},{"key":"5014_CR14","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/01.mph.0000212991.64435.f0","volume":"28","author":"MR Pranzatelli","year":"2006","unstructured":"Pranzatelli MR, Tate ED, Travelstead AL et al (2006) Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome. J Pediatr Hematol Oncol 28:585\u2013593","journal-title":"J Pediatr Hematol Oncol"},{"key":"5014_CR15","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/(SICI)1096-911X(199704)28:4<284::AID-MPO7>3.0.CO;2-E","volume":"29","author":"C Russo","year":"1997","unstructured":"Russo C et al (1997) Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the pediatric oncology group. Med Pediatr Oncol 29:284\u2013288","journal-title":"Med Pediatr Oncol"},{"issue":"1","key":"5014_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/1043454204272560","volume":"22","author":"ED Tate","year":"2005","unstructured":"Tate ED et al (2005) Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome. J Pediatr Oncol Nurs 22(1):18\u201319","journal-title":"J Pediatr Oncol Nurs"},{"key":"5014_CR17","doi-asserted-by":"crossref","unstructured":"Patel A et al (2020) Treatment and revaccination of children with paraneoplastic opsoclonus-myoclonus-ataxia syndrome and neuroblastoma: the memorial sloan kettering experience. Pediatr Blood Cancer 67(8):e28319","DOI":"10.1002\/pbc.28319"},{"key":"5014_CR18","doi-asserted-by":"crossref","unstructured":"Wilbur C, Yea C, Licht C, Irwin MS, Yeh EA (2019) An upfront immunomodulatory therapy protocol for pediatric opsoclonus-myoclonus syndrome. Pediatr Blood Cancer 66(8):e27776","DOI":"10.1002\/pbc.27776"}],"container-title":["Pediatric Surgery International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-021-05014-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00383-021-05014-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-021-05014-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T16:03:23Z","timestamp":1641657803000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00383-021-05014-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,21]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["5014"],"URL":"https:\/\/doi.org\/10.1007\/s00383-021-05014-w","relation":{},"ISSN":["0179-0358","1437-9813"],"issn-type":[{"type":"print","value":"0179-0358"},{"type":"electronic","value":"1437-9813"}],"subject":[],"published":{"date-parts":[[2021,9,21]]},"assertion":[{"value":"13 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}